The CoreValve US Pivotal Trial

Seminars in Thoracic and Cardiovascular Surgery

Volumn 26, Issue 3, 2014, Pages 179-186

  Barker, Colin M ^a   Reardon, Michael J ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

CoreValve; Extreme risk; High risk; Pivotal study; TAVR

Indexed keywords

AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; CARDIOVASCULAR EQUIPMENT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DISEASE REGISTRY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; METHODOLOGY; MORTALITY; NOTE; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL RISK; SURVIVAL TIME; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT RESPONSE; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; DEVICES; EVIDENCE BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84927926624     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2014.10.001     Document Type: Article

References (17)

1. Carabello B.A., Paulus W.J. Aortic stenosis. Lancet 2009, 373:956-966.
2. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006, 48:e1-e148.
3. Iung B., Cachier A., Baron G., et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery?. Eur Heart J 2005, 26:2714-2720.
4. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
5. Popma J.J., Adams D.H., Reardon M.J., et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014, 63:972-1981.
6. Adams D.H., Popma J.J., Reardon M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014, 370:1790-1798.
7. Ramlawi B., Bedeir K., Barker C., et al. Direct aortic and subclavian access for transcatheter aortic valve replacement: Decision making and technique. J Thorac Cardiovasc Surg 2014, 148:353-356.
8. Agarwal A., Kini A.S., Attanti S., et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005, 95:43-47.
9. Klein A., Lee K., Gera A., et al. Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis. J Interv Cardiol 2006, 19:269-275.
10. Shareghi S., Rasouli L., Shavelle D.M., et al. Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol 2007, 19:1-5.
11. Sack S., Kahlert P., Khandanpour S., et al. Revival of an old method with new techniques: Balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 2008, 97:288-297.
12. To A.C., Zeng I., Coverdale H.A. Balloon aortic valvuloplasty in adults-A 10-year review of Auckland[U+05F3]s experience. Heart Lung Circ 2008, 17:468-474.
13. Kapadia S.R., Goel S.S., Svensson L., et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009, 137:1430-1435.
14. Yamen E., Daniels D.V., Van H., et al. Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty. Catheter Cardiovasc Interv 2010, 75:794-798.
15. Leon M.B., Piazza N., Nikolsky E., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217.
16. Reardon M.J., Adams D.H., Coselli J., et al. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk for surgery. J Thorac Cardiovasc Surg 2014, http//:dx.doi.org/10.1016/j.jtcvs.2014.07.020. [Epub ahead of print].
17. Nishimura R.A., Otto C.M., Bonow R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014, 148:e1-e132.